HER2(+) mCRC patients with exon 20 R784G substitution mutation do not respond to the cetuximab therapy

Gharib, E; Salmanipour, R; Mojarad, EN; Taleghani, MY; Sarlak, S; Malekzade-Moghani, M; Nasrabadi, PN; Meiary, MA; Aghdaei, HA; Zali, MR

Mojarad, EN (reprint author), Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Gastroenterol & Liver Dis Res Ctr, Yeman St,Chamran Expressway,POB 19857-17411, Tehran, Iran.

JOURNAL OF CELLULAR PHYSIOLOGY, 2019; 234 (8): 13137